Table 1 Characteristics of study subjects
All patients (n = 84) | Hospital mortality | 1 year follow-up | |||||
|---|---|---|---|---|---|---|---|
Survivors (n = 74) | Non survivors (n = 10) | p | Survivors (n = 66) | Non survivors (n = 18) | p | ||
Age, years | 70.3 ± 13.6 | 68.4 ± 13.0 | 84.0 ± 9.0 | 0.001 | 67.6 ± 13.1 | 80.2 ± 10.7 | < 0.001 |
Sex, male | 55 (65.5%) | 51 (68.9%) | 4 (40.0%) | 0.087 | 46 (69.7%) | 9 (50.0%) | 0.119 |
GRACE risk score | 118.7 ± 34.8 | 114.2 ± 33.4 | 151.6 ± 27.4 | 0.001 | 109.6 ± 30.3 | 153.8 ± 28.9 | < 0.001 |
STEMI | 25 (29,8%) | 22 (29,7%) | 3 (30,0%) | 1.000 | 20 (30,3%) | 5 (27,8%) | 0.835 |
Risk factors for ACS | |||||||
Systemic hypertension | 63 (75.0%) | 53 (71.6%) | 10 (100.0%) | 0.060 | 47 (71.2%) | 16 (88.9%) | 0.218 |
Diabetes mellitus | 37 (44.0%) | 33 (44.6%) | 4 (40.0%) | 1.000 | 26 (39.4%) | 11 (61.1%) | 0.100 |
Dislipemia | 49 (58.3%) | 44 (59.5%) | 5 (50.0%) | 0.570 | 38 (57.6%) | 11 (61.1%) | 0.787 |
Known family history of cardiovascular diseases | 2 (2.4%) | 2 (2.7%) | 0 (0.0%) | 1.000 | 2 (3.0%) | 0 (0.0%) | 1.000 |
Smoking | 50 (59.5%) | 45 (60.8%) | 5 (50.0%) | 0.520 | 42 (63.6%) | 8 (44.4%) | 0.141 |
Previous history of coronary artery disease | 28 (33.3%) | 24 (32.4%) | 4 (40.0%) | 0.720 | 17 (25.8%) | 11 (61.1%) | 0.010 |
Comorbidity: | |||||||
Hyperuricemia | 3 (3.6%) | 2 (2.7%) | 1 (10.0%) | 0.320 | 2 (3.0%) | 1 (5.6%) | 0.520 |
Kidney disease | 12 (14.3%) | 7 (9.5%) | 5 (50.0%) | 0.001 | 5 (7.6%) | 7 (38.9%) | 0.001 |
Lung disease | 15 (17.9%) | 13 (17.6%) | 2 (20.0%) | 1.000 | 10 (15.2%) | 5 (27.8%) | 0.210 |
Hepatic disease | 1 (1.2%) | 1 (1.4%) | 0 (0.0%) | 1.000 | (1.5%) | 0 (0.0%) | 1.000 |
Cardiomyopathy | 2 (2.4%) | 1 (1.4%) | 1 (10.0%) | 0.220 | 0 (0.0%) | 2 (11.1%) | 0.040 |
Valvular heart | 4 (4.8%) | 3 (4.1%) | 1 (10.0%) | 0.400 | 1 (1.5%) | 3 (16.7%) | 0.027 |